Table of Contents
1. Executive summary
2. Market Introduction
2.1. Definition
2.2. Scope of the Study
2.2.1. Research Objective
2.2.2. Assumptions
2.2.3. Limitations
3. Research Methodology
3.1. Overview
3.2. Data Mining
3.3. Secondary Research
3.4. Primary Research
3.4.1. Primary Interviews and Information Gathering Process
3.4.2. Breakdown of Primary Respondents
3.5. Forecasting Model
3.6. Market Size Estimation
3.6.1. Bottom-Up Approach
3.6.2. Top-Down Approach
3.7. Data Triangulation
3.8. Validation
4. Market Dynamics
4.1. Overview
4.2. Drivers
4.3. Restraints
4.4. Opportunities
5. Market Factor Analysis
5.1. Value Chain Analysis
5.2. Porter’s Five Forces Analysis
5.2.1. Bargaining Power of Suppliers
5.2.2. Bargaining Power of Buyers
5.2.3. Threat of New Entrants
5.2.4. Threat of Substitutes
5.2.5. Intensity of Rivalry
5.3. COVID-19 Impact Analysis
5.3.1. Market Impact Analysis
5.3.2. Regional Impact
5.3.3. Opportunity and Threat Analysis
6. GLOBAL BONE MARROW TRANSPLANT MARKET, BY Type
6.1. Overview
6.2. Autologous Transplant
6.3. Allogenic Transplant
6.4. Others
7. GLOBAL BONE MARROW TRANSPLANT MARKET, BY Treatment Type
7.1. Overview
7.2. Leukemia
7.3. Lymphoma
7.4. Myeloma
7.5. Myelodysplastic Syndrome
7.6. Myeloproliferative Disorders
7.7. Aplastic Anemia
7.8. Solid Tumors
7.9. Sickle Cell Anemia
7.10. Thalassemia
7.11. Others
8. GLOBAL BONE MARROW TRANSPLANT MARKET, by End User
8.1. Overview
8.2. Hospitals
8.3. Multi-specialty Clinics
8.4. Ambulatory Surgical Centers
9. GLOBAL BONE MARROW TRANSPLANT MARKET, by Region
9.1. Overview
9.1. North America
9.1.1. US
9.1.2. Canada
9.2. Europe
9.2.1. Germany
9.2.2. France
9.2.3. UK
9.2.4. Italy
9.2.5. Spain
9.2.6. Rest of Europe
9.3. Asia-Pacific
9.3.1. China
9.3.2. India
9.3.3. Japan
9.3.4. South Korea
9.3.5. Australia
9.3.6. Rest of Asia-Pacific
9.4. Rest of the World
9.4.1. Middle East
9.4.2. Africa
9.4.3. Latin America
10. Competitive Landscape
10.1. Overview
10.2. Competitive Analysis
10.3. Market Share Analysis
10.4. Major Growth Strategy in the Global Bone Marrow Transplant Market,
10.5. Competitive Benchmarking
10.6. Leading Players in Terms of Number of Developments in the Global Bone Marrow Transplant Market,
10.7. Key Developments and Growth Strategies
10.7.1. New Product Launch/Service Deployment
10.7.2. Merger & Acquisitions
10.7.3. Joint Ventures
10.8. Major Players Financial Matrix
10.8.1. Sales & Operating Income, 2022
10.8.2. Major Players R&D Expenditure. 2022
11. Company ProfileS
11.1. Lonza
11.1.1. Company Overview
11.1.2. Financial Overview
11.1.3. Products Offered
11.1.4. Key Developments
11.1.5. SWOT Analysis
11.1.6. Key Strategies
11.2. Merck KgaA
11.2.1. Company Overview
11.2.2. Financial Overview
11.2.3. Products Offered
11.2.4. Key Developments
11.2.5. SWOT Analysis
11.2.6. Key Strategies
11.3. Sanofi
11.3.1. Company Overview
11.3.2. Financial Overview
11.3.3. Products Offered
11.3.4. Key Developments
11.3.5. SWOT Analysis
11.3.6. Key Strategies
11.4. AllCells
11.4.1. Company Overview
11.4.2. Financial Overview
11.4.3. Products Offered
11.4.4. Key Developments
11.4.5. SWOT Analysis
11.4.6. Key Strategies
11.5. STEMCELL Technologies Inc.
11.5.1. Company Overview
11.5.2. Financial Overview
11.5.3. Products Offered
11.5.4. Key Developments
11.5.5. SWOT Analysis
11.5.6. Key Strategies
11.6. Charles River Laboratories
11.6.1. Company Overview
11.6.2. Financial Overview
11.6.3. Products Offered
11.6.4. Key Developments
11.6.5. SWOT Analysis
11.6.6. Key Strategies
11.7. Beike Biotechnology Co. Ltd.
11.7.1. Company Overview
11.7.2. Financial Overview
11.7.3. Products Offered
11.7.4. Key Developments
11.7.5. SWOT Analysis
11.7.6. Key Strategies
11.8. FUJIFILM Cellular Dynamics Inc.
11.8.1. Company Overview
11.8.2. Financial Overview
11.8.3. Products Offered
11.8.4. Key Developments
11.8.5. SWOT Analysis
11.8.6. Key Strategies
11.9. CORESTEM, Inc.
11.9.1. Company Overview
11.9.2. Financial Overview
11.9.3. Products Offered
11.9.4. Key Developments
11.9.5. SWOT Analysis
11.9.6. Key Strategies
11.10. Gamida Cell
11.10.1. Company Overview
11.10.2. Financial Overview
11.10.3. Products Offered
11.10.4. Key Developments
11.10.5. SWOT Analysis
11.11. Lifeline Cell Technology.
11.11.1. Company Overview
11.11.2. Financial Overview
11.11.3. Products Offered
11.11.4. Key Developments
11.11.5. SWOT Analysis
11.11.6. Key Strategies
11.12. Mesoblast Ltd
11.12.1. Company Overview
11.12.2. Financial Overview
11.12.3. Products Offered
11.12.4. Key Developments
11.12.5. SWOT Analysis
11.12.6. Key Strategies
11.13. PromoCell GmbH
11.13.1. Company Overview
11.13.2. Financial Overview
11.13.3. Products Offered
11.13.4. Key Developments
11.13.5. SWOT Analysis
11.13.6. Key Strategies
12. Appendix
12.1. References
12.2. Related Reports
LIST OF TABLES
TABLE 1 Global BONE MArrow TRANSPLANT Market, Synopsis, 2018-2032
TABLE 2 Global BONE MArrow TRANSPLANT Market, Estimates & Forecast, 2018-2032 (USD BILLION)
TABLE 3 GLOBAL BONE MARROW TRANSPLANT MARKET, BY Type, 2018-2032 (USD BILLION)
TABLE 4 GLOBAL BONE MARROW TRANSPLANT MARKET, BY Treatment Type, 2018-2032 (USD BILLION)
TABLE 5 GLOBAL BONE MARROW TRANSPLANT MARKET, by End User, 2018-2032 (USD BILLION)
TABLE 6 North America: BONE MARROW TRANSPLANT MARKET, BY Type, 2018-2032 (USD BILLION)
TABLE 7 North America: BONE MARROW TRANSPLANT MARKET, BY Treatment Type, 2018-2032 (USD BILLION)
TABLE 8 North america: BONE MARROW TRANSPLANT MARKET, BY End User, 2018-2032 (USD BILLION)
TABLE 9 US: BONE MARROW TRANSPLANT MARKET, BY Type, 2018-2032 (USD BILLION)
TABLE 10 US: BONE MARROW TRANSPLANT MARKET, BY Treatment Type, 2018-2032 (USD BILLION)
TABLE 11 US: BONE MARROW TRANSPLANT MARKET, BY End User, 2018-2032 (USD BILLION)
TABLE 12 Canada: BONE MARROW TRANSPLANT MARKET, BY Type, 2018-2032 (USD BILLION)
TABLE 13 Canada: BONE MARROW TRANSPLANT MARKET, BY Treatment Type, 2018-2032 (USD BILLION)
TABLE 14 Canada: BONE MARROW TRANSPLANT MARKET, BY End User, 2018-2032 (USD BILLION)
TABLE 15 Europe: BONE MARROW TRANSPLANT MARKET, BY Type, 2018-2032 (USD BILLION)
TABLE 16 Europe: BONE MARROW TRANSPLANT MARKET, BY Treatment Type, 2018-2032 (USD BILLION)
TABLE 17 Europe: BONE MARROW TRANSPLANT MARKET, BY End User, 2018-2032 (USD BILLION)
TABLE 18 germany: BONE MARROW TRANSPLANT MARKET, BY Type, 2018-2032 (USD BILLION)
TABLE 19 germany: BONE MARROW TRANSPLANT MARKET, BY Treatment Type, 2018-2032 (USD BILLION)
TABLE 20 germany: BONE MARROW TRANSPLANT MARKET, BY End User, 2018-2032 (USD BILLION)
TABLE 21 FRANCE: BONE MARROW TRANSPLANT MARKET, BY Type, 2018-2032 (USD BILLION)
TABLE 22 FRANCE: BONE MARROW TRANSPLANT MARKET, BY Treatment Type, 2018-2032 (USD BILLION)
TABLE 23 France: BONE MARROW TRANSPLANT MARKET, BY End User, 2018-2032 (USD BILLION)
TABLE 24 italy: BONE MARROW TRANSPLANT MARKET, BY Type, 2018-2032 (USD BILLION)
TABLE 25 italy: BONE MARROW TRANSPLANT MARKET, BY Treatment Type, 2018-2032 (USD BILLION)
TABLE 26 italy: BONE MARROW TRANSPLANT MARKET, BY End User, 2018-2032 (USD BILLION)
TABLE 27 spain: BONE MARROW TRANSPLANT MARKET, BY Type, 2018-2032 (USD BILLION)
TABLE 28 spain: BONE MARROW TRANSPLANT MARKET, BY Treatment Type, 2018-2032 (USD BILLION)
TABLE 29 spain: BONE MARROW TRANSPLANT MARKET, BY End User, 2018-2032 (USD BILLION)
TABLE 30 UK: BONE MARROW TRANSPLANT MARKET, BY Type, 2018-2032 (USD BILLION)
TABLE 31 UK: BONE MARROW TRANSPLANT MARKET, BY Treatment Type, 2018-2032 (USD BILLION)
TABLE 32 uk: BONE MARROW TRANSPLANT MARKET, BY end uSer, 2018-2032 (USD BILLION)
TABLE 33 rest of europe: BONE MARROW TRANSPLANT MARKET, BY Type, 2018-2032 (USD BILLION)
TABLE 34 rest of europe: BONE MARROW TRANSPLANT MARKET, BY Treatment Type, 2018-2032 (USD BILLION)
TABLE 35 REST OF EUROPE: BONE MARROW TRANSPLANT MARKET, BY End User, 2018-2032 (USD BILLION)
TABLE 36 Asia-Pacific: BONE MARROW TRANSPLANT MARKET, BY Type, 2018-2032 (USD BILLION)
TABLE 37 Asia-Pacific: BONE MARROW TRANSPLANT MARKET, BY Treatment Type, 2018-2032 (USD BILLION)
TABLE 38 ASIA-PACIFIC: BONE MARROW TRANSPLANT MARKET, BY End User, 2018-2032 (USD BILLION)
TABLE 39 japan: BONE MARROW TRANSPLANT MARKET, BY Type, 2018-2032 (USD BILLION)
TABLE 40 japan: BONE MARROW TRANSPLANT MARKET, BY Treatment Type, 2018-2032 (USD BILLION)
TABLE 41 japan: BONE MARROW TRANSPLANT MARKET, BY End User, 2018-2032 (USD BILLION)
TABLE 42 china: BONE MARROW TRANSPLANT MARKET, BY Type, 2018-2032 (USD BILLION)
TABLE 43 china: BONE MARROW TRANSPLANT MARKET, BY Treatment Type, 2018-2032 (USD BILLION)
TABLE 44 china: BONE MARROW TRANSPLANT MARKET, BY End User, 2018-2032 (USD BILLION)
TABLE 45 india: BONE MARROW TRANSPLANT MARKET, BY Type, 2018-2032 (USD BILLION)
TABLE 46 india: BONE MARROW TRANSPLANT MARKET, BY Treatment Type, 2018-2032 (USD BILLION)
TABLE 47 india: BONE MARROW TRANSPLANT MARKET, BY End User, 2018-2032 (USD BILLION)
TABLE 48 australia: BONE MARROW TRANSPLANT MARKET, BY Type, 2018-2032 (USD BILLION)
TABLE 49 australia: BONE MARROW TRANSPLANT MARKET, BY Treatment Type, 2018-2032 (USD BILLION)
TABLE 50 australia: BONE MARROW TRANSPLANT MARKET, BY End User, 2018-2032 (USD BILLION)
TABLE 51 south korea: BONE MARROW TRANSPLANT MARKET, BY Type, 2018-2032 (USD BILLION)
TABLE 52 south korea: BONE MARROW TRANSPLANT MARKET, BY Treatment Type, 2018-2032 (USD BILLION)
TABLE 53 south korea: BONE MARROW TRANSPLANT MARKET, BY End User, 2018-2032 (USD BILLION)
TABLE 54 rest of asia-pacific: BONE MARROW TRANSPLANT MARKET, BY Type, 2018-2032 (USD BILLION)
TABLE 55 rest of asia-pacific: BONE MARROW TRANSPLANT MARKET, BY Treatment Type, 2018-2032 (USD BILLION)
TABLE 56 REST OF ASIA-PACIFIC: BONE MARROW TRANSPLANT MARKET, BY End User, 2018-2032 (USD BILLION)
TABLE 57 rest of the world: BONE MARROW TRANSPLANT MARKET, BY Type, 2018-2032 (USD BILLION)
TABLE 58 rest of the world: BONE MARROW TRANSPLANT MARKET, BY Treatment Type, 2018-2032 (USD BILLION)
TABLE 59 REST OF THE WORLD: BONE MARROW TRANSPLANT MARKET, BY End User, 2018-2032 (USD BILLION)
TABLE 60 Middle east: BONE MARROW TRANSPLANT MARKET, BY Type, 2018-2032 (USD BILLION)
TABLE 61 Middle east: BONE MARROW TRANSPLANT MARKET, BY Treatment Type, 2018-2032 (USD BILLION)
TABLE 62 MIDDLE EAST: BONE MARROW TRANSPLANT MARKET, BY End User, 2018-2032 (USD BILLION)
TABLE 63 Africa: BONE MARROW TRANSPLANT MARKET, BY Type, 2018-2032 (USD BILLION)
TABLE 64 Africa: BONE MARROW TRANSPLANT MARKET, BY Treatment Type, 2018-2032 (USD BILLION)
TABLE 65 Africa: BONE MARROW TRANSPLANT MARKET, BY END USER, 2018-2032 (USD BILLION)
TABLE 66 Latin america: BONE MARROW TRANSPLANT MARKET, BY Type, 2018-2032 (USD BILLION)
TABLE 67 Latin america: BONE MARROW TRANSPLANT MARKET, BY Treatment Type, 2018-2032 (USD BILLION)
TABLE 68 LATIN AMERICA: BONE MARROW TRANSPLANT MARKET, BY END USER, 2018-2032 (USD BILLION)
LIST OF FIGURES
FIGURE 1 Research Process
FIGURE 2 Market Structure for the Global BONE MArrow TRANSPLANT Market
FIGURE 3 Market Dynamics for the Global BONE MArrow TRANSPLANT Market
FIGURE 4 Global BONE MArrow TRANSPLANT Market, Share (%), BY Type, 2022
FIGURE 5 Global BONE MArrow TRANSPLANT Market, Share (%), BY Treatment Type, 2022
FIGURE 6 Global BONE MArrow TRANSPLANT Market, Share (%), BY End User, 2022
FIGURE 7 Global BONE MArrow TRANSPLANT Market, Share (%), by Region, 2022
FIGURE 8 north AMERICA: BONE MARROW TRANSPLANT MARKET, SHARE (%), BY REGION, 2022
FIGURE 9 Europe: BONE MARROW TRANSPLANT MARKET, SHARE (%), BY REGION, 2022
FIGURE 10 Asia-Pacific: BONE MARROW TRANSPLANT MARKET, SHARE (%), BY REGION, 2022
FIGURE 11 Rest of the world: BONE MARROW TRANSPLANT MARKET, SHARE (%), BY REGION, 2022
FIGURE 12 Global BONE MArrow TRANSPLANT Market: Company Share Analysis, 2022 (%)
FIGURE 13 Lonza: FINANCIAL OVERVIEW SNAPSHOT
FIGURE 14 Lonza: SWOT ANALYSIS
FIGURE 15 Merck KgaA: FINANCIAL OVERVIEW SNAPSHOT
FIGURE 16 Merck KgaA: SWOT ANALYSIS
FIGURE 17 Sanofi: FINANCIAL OVERVIEW SNAPSHOT
FIGURE 18 Sanofi: SWOT ANALYSIS
FIGURE 19 AllCells: FINANCIAL OVERVIEW SNAPSHOT
FIGURE 20 AllCells: SWOT ANALYSIS
FIGURE 21 STEMCELL Technologies Inc.: FINANCIAL OVERVIEW SNAPSHOT
FIGURE 22 STEMCELL Technologies Inc.: SWOT ANALYSIS
FIGURE 23 Charles River Laboratories: FINANCIAL OVERVIEW SNAPSHOT
FIGURE 24 Charles River Laboratories: SWOT ANALYSIS
FIGURE 25 Beike Biotechnology Co. Ltd.: FINANCIAL OVERVIEW SNAPSHOT
FIGURE 26 Beike Biotechnology Co. Ltd.: SWOT ANALYSIS
FIGURE 27 FUJIFILM Cellular Dynamics Inc.: FINANCIAL OVERVIEW SNAPSHOT
FIGURE 28 FUJIFILM Cellular Dynamics Inc.: SWOT ANALYSIS
FIGURE 29 CORESTEM Inc.: FINANCIAL OVERVIEW SNAPSHOT
FIGURE 30 CORESTEM Inc.: SWOT ANALYSIS
FIGURE 31 Gamida Cell: FINANCIAL OVERVIEW SNAPSHOT
FIGURE 32 Gamida Cell: SWOT ANALYSIS
FIGURE 33 Lifeline Cell Technology: FINANCIAL OVERVIEW SNAPSHOT
FIGURE 34 Lifeline Cell Technology: SWOT ANALYSIS
FIGURE 35 Mesoblast Ltd: FINANCIAL OVERVIEW SNAPSHOT
FIGURE 36 Mesoblast Ltd: SWOT ANALYSIS
FIGURE 37 PromoCell GmbH.: FINANCIAL OVERVIEW SNAPSHOT
FIGURE 38 PromoCell GmbH.: SWOT ANALYSIS
